Helix BioPharma Corp. (HBP.TO)
0.82
-0.16
(-16.33%)
CAD |
TSX |
Oct 23, 16:00
Helix BioPharma Enterprise Value : 60.15M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 60.15M |
| October 22, 2026 | 72.37M |
| October 21, 2026 | 72.37M |
| October 20, 2026 | 72.37M |
| October 19, 2026 | 72.37M |
| October 16, 2026 | 72.37M |
| October 15, 2026 | 67.02M |
| October 14, 2026 | 67.78M |
| October 13, 2026 | 70.84M |
| October 09, 2026 | 67.78M |
| October 08, 2026 | 67.78M |
| October 07, 2026 | 66.26M |
| October 06, 2026 | 67.78M |
| October 05, 2026 | 72.37M |
| October 02, 2026 | 72.37M |
| October 01, 2026 | 70.08M |
| September 30, 2026 | 67.02M |
| September 29, 2026 | 78.48M |
| September 28, 2026 | 84.59M |
| September 25, 2026 | 76.19M |
| September 24, 2026 | 81.53M |
| September 23, 2026 | 81.53M |
| September 22, 2026 | 86.88M |
| September 21, 2026 | 108.27M |
| September 18, 2026 | 108.27M |
| Date | Value |
|---|---|
| September 17, 2026 | 104.45M |
| September 16, 2026 | 104.45M |
| September 15, 2026 | 102.92M |
| September 14, 2026 | 104.45M |
| September 11, 2026 | 108.27M |
| September 10, 2026 | 113.61M |
| September 09, 2026 | 122.01M |
| September 08, 2026 | 135.00M |
| September 04, 2026 | 135.00M |
| September 03, 2026 | 138.82M |
| September 02, 2026 | 154.09M |
| September 01, 2026 | 134.23M |
| August 31, 2026 | 144.93M |
| August 28, 2026 | 142.64M |
| August 27, 2026 | 142.64M |
| August 26, 2026 | 145.69M |
| August 25, 2026 | 149.51M |
| August 24, 2026 | 151.04M |
| August 21, 2026 | 147.98M |
| August 20, 2026 | 150.27M |
| August 19, 2026 | 150.27M |
| August 18, 2026 | 150.27M |
| August 17, 2026 | 151.80M |
| August 14, 2026 | 140.34M |
| August 13, 2026 | 135.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Microbix Biosystems, Inc. | 43.39M |
| Sernova Biotherapeutics, Inc. | 56.09M |
| Hemostemix, Inc. | 14.64M |
| Medicenna Therapeutics Corp. | 33.64M |
| Spectral Medical, Inc. | 317.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.671M |
| Total Expenses (Quarterly) | 0.671M |
| EPS Diluted (Quarterly) | -0.0088 |
| Earnings Yield | -5.37% |
| Normalized Earnings Yield | -5.366 |